Durvalumab vs Zolpidem

Durvalumab vs Zolpidem: Overview

This comparison examines the pharmacological differences between Durvalumab and Zolpidem.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Zolpidem: Selective GABA-A receptor alpha-1 subunit agonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Zolpidem — 2.5 hours.

Chemical Properties

Molecular Formula: Zolpidem — C19H21N3O.

Molecular Weight: Zolpidem — 307.3950 g/mol.

Type: Durvalumab — Antibody; Zolpidem — Small molecule.